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The CD3ζ forms part of theT cell receptor (TCR) where it plays an important role in coupling
antigen recognition to several intracellular signal-transduction pathways leading to T cell
effector functions. Down regulation of CD3ζ leads to impairment of immune responses
including reduced cell proliferation and cytokine production. In experimental models,
helminth parasites have been shown to modulate immune responses directed against
them and unrelated antigens, so called bystander antigens, but there is a lack of studies
validating these observations in humans.This study investigated the relationship between
expression levels of the TCR CD3ζ chain with lymphocyte cell proliferation during human
infection with the helminth parasite, Schistosoma haematobium, which causes uro-genital
schistosomiasis. Using flow cytometry, peripheral blood mononuclear cells (PBMCs) from
individuals naturally exposed to S. haematobium in rural Zimbabwe were phenotyped, and
expression levels of CD3ζ onT cells were related to intensity of infection. In this population,
parasite infection intensity was inversely related to CD3ζ expression levels (p<0.05), con-
sistent with downregulation of CD3ζ expression during helminth infection. Furthermore,
PBMC proliferation was positively related to expression levels of CD3ζ (p<0.05) after
allowing for confounding variables (host age, sex, and infection level). CD3ζ expression
levels had a differing relationship between immune correlates of susceptibility and immu-
nity, measured by antibody responses, indicating a complex relationship between immune
activation status and immunity. The relationships between the CD3ζ chain of the TCR and
schistosome infection, PBMC proliferation and schistosome-specific antibody responses
have not previously been reported, and these results may indicate a mechanism for the
impaired T cell proliferative responses observed during human schistosome infection.
Keywords:T cells, CD3ζ, schistosomiasis, human, helminth, downmodulation, antibody, pathology
INTRODUCTION
The T cell receptor (TCR) complex, comprising of the TCR, a
CD3ζ chain (CD3ζ) and CD3 co-receptor, has a tightly controlled
assembly and expression within cells (1). CD3ζ is an integral part
of the signaling pathway involved in TCR signaling (2), and its
downregulation has been reported in numerous pathologies and
conditions associated with chronic inflammation whilst the TCR
on the cell surface remains present at normal concentrations (3).
Thus, the CD3ζ chain is considered a “sensor” of sustained expo-
sure to chronic inflammatory immune responses, a mechanism
to restrict the magnitude of T cell responses and counteracting
an overzealous immune reaction (3). Thus far there have been
reports of a downregulated CD3ζ chain in pathologies such as
cancers, arthritis, systemic lupus erythematosus, HIV, and leprosy,
all conditions associated with impaired T cell functions (3–6).
The helminth parasite Schistosoma haematobium causes uro-
genital schistosomiasis; a chronic condition typically associated
with downregulated immune responses (7). Chronic inflamma-
tion associated with schistosomiasis is a hallmark of pathology
(8, 9), and experimental models suggest that tissue inflammation
is largely CD4+ T helper (Th) 2 driven (10, 11). It is unclear
whether the TCR complex is modified in schistosomiasis in the
same way as in the Th1 polarized inflammatory diseases in which
CD3ζ has previously been studied (3). The immune response to
schistosome infection typically consists of elevated levels of reg-
ulatory cytokines such as IL-10 and TGFβ (12, 13) and results in
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downregulation of T cell proliferation (14), cytokine production
(15, 16), and hyporesponsiveness (17). Such a modulated immune
response is characteristic of infected individuals in endemic envi-
ronments who are believed to tolerate infection, facilitating para-
site persistence, while at the same time limiting pathology associ-
ated with eggs laid by adult worms (18–20). The decreased prolif-
erative capacity of peripheral blood mononuclear cells (PBMCs)
during schistosome infection has been reported in both human
and experimental studies (21–23), and serves to minimize pathol-
ogy associated with host inflammatory responses (16). How-
ever, this downregulation and suppression of immune responses
can also have spill-over effects into other areas of the immune
response. For example, helminths are known to affect the host’s
ability to mount an effective immune response following vaccina-
tion, leading to vaccine failure (24,25). Mechanisms for downregu-
lating the immune response in helminth infection have been inves-
tigated in experimental models, and focus primarily on myeloid
cells and T regulatory cells (16, 26). Mechanisms associated with
control and downregulation of the human immune response have
generated interest from the fields of vaccine research, as well as
of autoimmunity and allergy due to the potential for therapeutic
interventions for these conditions (27–29).
We describe here levels of CD3ζ expression on T cells, PBMC
proliferation, and antibody responses from a cohort of individ-
uals living in a schistosome endemic area of rural Zimbabwe.
We hypothesized that CD3ζ expression may be downregulated in
chronic schistosomiasis and thus be related to S. haematobium
infection levels within the cohort. Furthermore, we relate CD3ζ
expression to schistosome-specific antibodies commonly associ-
ated with protection or susceptibility to infection. Our study is the
first to show that CD3ζ expression on T cells is reduced during
schistosome infection suggesting that this may be a mechanism
for immune suppression in schistosomiasis.
MATERIALS AND METHODS
ETHICAL APPROVAL
Ethical and institutional approval was granted by the Medical
Research Council of Zimbabwe and the University of Zimbabwe’s
Institutional Review Board. Local permission for the study was
granted by the Provincial Medical Director. The study design, aims,
and procedures were explained in the local language, Shona, prior
to enrollment. Participants were free to drop out of the study at
any time and informed written consent/assent was obtained from
all participants and/or their guardians prior to taking part in the
study and to receiving antihelminthic treatment.
STUDY DESIGN
The study presented here was part of a larger on-going immuno-
epidemiological study based in Mashonaland East, Zimbabwe
where S. haematobium is endemic as is described elsewhere (30).
The area has a low prevalence of soil transmitted helminths (STH)
and Schistosoma mansoni (31), and the residents are subsistence
farmers with frequent contact with S. haematobium infected water
for purposes of bathing, washing, and collecting water. Recruit-
ment into the study was school based and the wider community
was also invited to participate. Residential history, antihelminthic
treatment history, and water contact habits of the participants
were captured through questionnaire. Following sample collec-
tion, participants were offered treatment with the antihelminthic
drug praziquantel at the recommended dose of 40 mg/kg of body
weight (32).
INCLUSION CRITERIA
In order to be included in this study participants had to meet the
following criteria: (1) be lifelong residents of the study area to
allow age to be used as a proxy for history of exposure to schis-
tosome infection, (2) have provided a minimum of two urine
and two stool samples on consecutive days for parasite detection,
(3) not have previously received antihelminthic treatment, (4) be
negative for co-infection with malaria, STH, S. mansoni, and HIV,
and (5) have provided a blood sample for serological and cellular
assays. From an initial cohort of 633 recruited individuals, 68 were
excluded for not meeting criteria 1–4 above and a further 184 did
not provide sufficient blood sample for both serological assays and
cell phenotyping. From the remaining 381 individuals, a cohort of
100 individuals was further selected to allow for, as far as possible,
equal numbers of females to males and an even distribution of ages
and infection prevalence. The final study group was dependent on
the participant’s PBMC sample yielding at least 106 cells to allow
enough cells for all experimental conditions. The final study group
consisted of 94 individuals and was divided into three age groups
as described in Table 1.
SAMPLE COLLECTION
From each participant, a stool and urine sample was collected on
three consecutive days and examined microscopically for the pres-
ence of S. haematobium eggs in urine, and S. mansoni and STH
eggs in stool using standard techniques (33, 34). Up to 20 ml of
venous blood was collected from each participant in heparinized
tubes and silicone-coated tubes (both from BD Biosciences, San
Jose, CA, USA), for collecting PBMCs, and serum. An additional
drop of blood was collected from each participant for microscopic
detection of malaria parasites and for HIV detection using Dou-
bleCheckGold™ HIV 1&2 Whole Blood Test (Orgenics Ltd.,Yavne,
Israel). PBMCs were isolated from the remaining tubes via density
gradient centrifugation using Lymphoprep™(Axis-Shield, Cam-
bridgeshire, UK). Isolated PBMCs were cryopreserved and stored
in liquid nitrogen in Zimbabwe prior to freighting to Edinburgh
in dry shippers.
ANTIBODY ASSAYS
Schistosome soluble worm antigen preparation (SWAP) specific
antibody serum levels for IgA, IgE, and IgG4 were quantified using
antibody ELISA. Lyophilized SWAP (Theodor Bilharz Institute,
Giza, Egypt) was reconstituted as described by Mutapi et al. (35).
ELISAs were conducted as previously reported (36), adding sam-
ple at a 1:20 dilution for IgA and IgE, and 1:100 dilution for IgG4
in 5% (weight/volume) skimmed milk powder. Secondary IgA
HRP-conjugated antibody (A-7032 Sigma, St Louis, MO, USA) was
added at a 1:1000 dilution, a 1:250 dilution for IgE (P-295, Dako,
Glostrup, Denmark), and at a 1:500 dilution for IgG4 (MCA517,
AbD Serotec, Oxford, UK). The colorimetric reaction was quanti-
fied with an ELISA reader at 405 nm. Each antibody ELISA was
performed in duplicate on the same day for all samples with
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Table 1 | Characteristics of study cohort.
Infection status Age group
5–10 years 11–15 years >16 years
Sh− Sh+ Sh− Sh+ Sh− Sh+
Sample size (no.) 25 15 17 13 15 9
Mean age in years (range) 7.76 (5–10) 7.60 (5–10) 13.06 (11–15) 12.54 (11–14) 29.73 (16–49) 27.11 (16–54)
Infection intensity 0 60.32 0 99.44 0 78.33
Infection range (SD) 0 1.33–185 (85.40) 0 0.33–523 (165.7) 0 0.33–550 (177.79)
Males:Females 8:17 11:4 9:8 8:5 2:13 3:6
All selected people of the cohort were negative for HIV, soil transmitted helminths and S. mansoni; infection intensity: eggs/10 ml urine; Sh−, negative for S.
haematobium, Sh+, positive for S. haematobium.
positive (high responders) and negative (Europeans who have
never traveled to helminth endemic areas) controls included on
all plates.
DETERMINING CD3ζ EXPRESSION
Cryopreserved PBMCs were thawed as previously described (37),
and resuspended at 5× 106 cells/ml in PBS. Cells were incubated
with 10% FCS at 4°C for 10 min prior to staining for 30 min
with PerCP-Cy5.5 conjugated anti-CD3 (clone OKT3 from eBio-
sciences, San Diego, CA, USA). Cells were permeabilized with
permeabilization buffer [made up of 0.1% NaAzide and 0.1%
saponin in Dulbecco’s PBS (Lonza, Verviers, Belgium)], and incu-
bated with FITC conjugated anti-CD3ζ antibody (clone 6B10.2
from BioLegend, San Diego, CA, USA). At least 50,000 live events
were acquired on an LSR II flow cytometer (BD Biosciences, San
Jose, CA, USA). Analysis was performed using FlowJo software
(TreeStar, USA) and mean fluorescence intensity (MFI) was cal-
culated for CD3 and CD3ζ. CD3ζ expression on T cells was deter-
mined according to expression levels on CD3 positive cells, and
normalized by subtracting the MFI of CD3 in the CD3 negative
population.
PROLIFERATION ASSAY
PBMCs were resuspended at 1× 106 cells per well, and stimulated
with mitogens to induce proliferation. Cells were cultured for a
total of 54 h at 37°C together with 50 ng/ml phorbol myristate
acetate (PMA) and 1 µg/ml phytohemagglutinin (PHA) (Sigma-
Aldrich, Dorset, UK), or cultured with X-VIVO medium as a nega-
tive control. After 36 h, the supernatant was removed and replaced
with fresh X-VIVO medium containing tritiated thymidine (3H-
Thymidine) (Amersham Biosciences, GE Healthcare, Little Chal-
font, UK) at a final concentration of 0.1 µCurie/well. After a 18-h
incubation at 37°C the plates were harvested and proliferation of
the cell populations quantified according to 3H-Thymidine cellu-
lar incorporation. Uptake of 3H-Thymidine was quantified using
a scintillation counter (Wallac-Perkin Elmer, MA, USA). Prolifer-
ation was quantified as counts per minute (cpm), and successful
proliferation determined as>1000 cpm after media subtraction.
STATISTICAL ANALYSIS
All statistical analyses were conducted using the statistical package
SPSS version 19 (IBM Corp., NY, USA). Data were analyzed using
parametric linear regression. The data were transformed in order
to meet assumptions of parametric tests. CD3ζ was measured as
MFI of CD3ζ on CD3 positive cells after subtracting the CD3ζ
MFI of the CD3 negative (non T cells) of the same individual.
Final measurement of CD3ζ was square-root transformed. Anti-
body level (after subtraction of the blank control) was square-root
transformed. Proliferation data, expressed as cpm were similarly
square-root transformed after subtraction of media control values.
Infection intensity was log transformed [log10 (x + 1)]. Categor-
ical variables were sex (male/female), and age group [5–10 years
(age group where infection is rising), 11–15 years (age group where
infection is peaking), or >16 years (age group where infection is
declining)].
Due to the possibility of gender and age dependent exposure
patterns in this population (38, 39), it was necessary to allow for
variation due to these factors prior to investigating the relationship
of interest (40). The relationship between CD3ζ expression and
infection intensity was determined via hierarchical linear regres-
sion analysis of infection intensity with CD3ζ expression, allowing
for variation due to age and sex before testing for the relationship
with infection intensity. The relationship between PBMC prolifer-
ation and CD3ζ expression for the whole cohort was determined
using a linear regression analysis, allowing for variation due to
sex, age group, and infection intensity. The relationship between
CD3 and CD3ζ, as well as between SWAP IgA and SEA IgA, and
IgE:IgG4 against SWAP was assessed for the whole cohort using
a partial correlation analysis controlling for age group, infection
intensity, and sex. For all statistical tests p≤ 0.05 was considered
significant.
RESULTS
CD3ζ CHAIN OF THE TCR IS DOWNREGULATED WITH INCREASING
LEVELS OF INFECTION
CD3ζ levels were measured on CD3+ T cells within the Zim-
babwean cohort as an indication of activation status of the T
cells. There was a significant and negative relationship between
the intensity of S. haematobium infection and CD3ζ expression
(Figure 1; Table 2). In order to confirm that this change was
not related to an overall downregulation of the TCR complex
(TCR) but due to a specific decrease in the CD3ζ chain, expres-
sion of the TCR co-receptor, CD3, was assessed in relation to CD3ζ
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FIGURE 1 | Scatter graph of Schistosoma haematobium infection
intensity [log10 (x +1); x axis] and CD3ζ expression onT cells (MFI; y
axis) for the whole cohort. β and p values from linear regression analysis
after allowing for age group (5–10, 11–15, 16+ years) and sex (male or
female) are shown.
Table 2 | Coefficients of the regression model relating CD3ζ to
schistosome infection intensity.
Standardized
residuals
Unstandardized
residuals
95% Confidence
interval
β Value p Value Beta SE Lower
bound
Upper
bound
Constant 81.86 3.99 73.93 89.80
Sex −0.08 0.46 −1.60 2.13 −5.82 2.63
Age group −0.06 0.59 −0.69 1.27 −0.54 0.59
Infection
intensity
−0.27 0.01 −3.34 1.30 −5.93 −0.75
The table shows standardized and unstandardized coefficients from regression
analysis. R2 =0.073. Significant values are shown in bold. β value for infection
intensity is represented on Figure 1.
SE, standard error.
expression as well as age and infection status. There was no signifi-
cant relationship between CD3ζ and CD3 (r =−0.116, p= 0.282),
confirming the relatively independent nature of CD3ζ expression
within the TCR (3). Furthermore, the decrease in CD3ζ with infec-
tion intensity was not related to total levels of TCR expression,
as CD3 levels were not significantly related to infection levels
(β= 0.160, p= 0.124, see Figure S1 in Supplementary Material).
CD3ζ LEVELS ARE POSITIVELY CORRELATED WITH PBMC
PROLIFERATION
Levels of CD3ζ expression on T cells are intrinsically related to
TCR activity and downstream immune responses, including cell
proliferation (41). We thus related levels of CD3ζ expression on
CD3 positive cells to the proliferative capacity of PBMCs from
the whole cohort of schistosome exposed individuals. PBMCs
from schistosome exposed individuals were stimulated for 54 h
with PMA and PHA in order to assess proliferative capacity of the
PBMCs independent of schistosome infection. The study showed
a significant positive association between PBMC proliferation and
FIGURE 2 | Relationship between CD3ζ expression onT cells (MFI; x
axis) and PBMC proliferation (cpm; y axis) for the whole cohort. β and
p values from regression analysis after allowing for age group (5–10, 11–15,
16+ years), sex (male or female), and infection intensity [log10 (x +1)] are
shown.
CD3ζ expression. The relationship was significant after allowing
for variation in sex, age, and infection intensity. Figure 2 shows the
relationship between CD3ζ expression levels and PBMC prolifera-
tive capacity after stimulation in this population. CD3 expression
was not related to PBMC proliferation (β=−0.025, p= 0.734).
Despite CD3ζ expression being significantly related to burden
of infection, PBMC proliferation was not significantly related to
the burden of schistosome infection (β=−0.168, p= 0.092).
CD3ζ LEVELS ARE NEGATIVELY CORRELATED TO PROTECTIVE IMMUNE
RESPONSES
Having shown the relationship between CD3ζ and infection inten-
sity, we were interested in whether this was related to immune
correlates to infection, as determined by antibody isotypes specific
to adult schistosome antigens. Antibody production to the SWAP
antigen was measured for IgA, IgG4, and IgE. Previous studies
from this population show IgA to be a potential marker for sus-
ceptibility to infection (42–44). Relatively high levels of IgG4 are
frequently produced in younger ages, thus it is considered to be a
marker for susceptibility to infection. In contrast, IgE levels found
to be higher in individuals who are more resistant to infection
or reinfection (45, 46). Frequently, IgE and IgG4 are compared
as ratios to better reflect changes in immunity on an individual
level, such that high IgE:IgG4 is considered a marker for resistance
to reinfection (45). As shown in Table 3, after controlling for sex
and age group, IgG4 was found to be positively associated with
infection intensity, while IgE and IgA did not show any signifi-
cant relationship with infection intensity. IgE:IgG4 demonstrated
a non-significant negative association with infection intensity.
When relating levels of these antibodies to CD3ζ levels, IgA had
a significant negative relationship with CD3ζ. There was also a sig-
nificant negative correlation between IgE:IgG4 with CD3ζ. Table 4
shows the r and p values from the correlation analyses that were
performed on the whole cohort.
DISCUSSION
Both human and experimental studies have shown diminished cell
proliferation in response to schistosome and bystander antigens
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Table 3 | R values from partial correlation between SWAP specific IgA,
IgE, or IgG4 levels and IgE:IgG4 against infection intensity.
Infection intensity
R value p Value df
SWAP IgA −0.013 0.901 86
SWAP IgE 0.117 0.277 86
SWAP IgG4 0.280 0.009 83
SWAP IgE:IgG4 −0.203 0.066 81
R values are from partial correlation, controlling for sex, and age group. Significant
relationships are indicated in bold.
df, degrees of freedom.
Table 4 | R values from partial correlation between SWAP specific IgA,
IgE, or IgG4 levels and IgE:IgG4 against CD3ζ expression.
CD3ζ
R value p Value df
SWAP IgA −0.292 0.006 85
SWAP IgE −0.182 0.092 85
SWAP IgG4 0.109 0.322 82
SWAP IgE:IgG4 −0.254 0.022 80
R values are from partial correlation, controlling for sex, age group, and infection
intensity. Significant relationships are indicated in bold.
df, degrees of freedom.
during chronic schistosome infection (15, 22, 23, 47). These
diminished responses are related to the presence of parasites (22,
48, 49). In limiting immune cell activation, pathology related to
schistosome worm antigens is also limited (16, 50). The aim of this
study was to investigate the relationship between expression levels
of the TCR CD3ζ chain with lymphocyte cell proliferation during
human infection with S. haematobium to determine if this is a pos-
sible mechanism through which T cell functions may be regulated.
CD3ζ levels are reported to be related to T cell responsiveness
and proliferative capacity (2, 3, 41), and infection with schisto-
somes is associated with reduced proliferative responses (15, 16).
Here, we investigated changes in the TCR CD3ζ chain in relation
to schistosome infection intensity, and show a previously unre-
ported negative association between CD3ζ levels and schistosome
worm burden. In addition,we show a positive relationship between
CD3ζ expression and PBMC proliferation, confirming the asso-
ciation between CD3ζ expression levels and PBMC proliferative
capacity (3, 26). The observed downregulation of CD3ζ expres-
sion in conjunction with increasing infection intensity may be
indicating a mechanism for downregulation of T cell proliferation
in schistosomiasis. Downregulation of the immune response in
schistosome infection is an important mechanism for modulating
pathological host immune responses associated with parasite eggs;
forming a balance between host immunity and successful parasite
establishment (20). Indeed, in experimental models, where the
ability to downregulate the immune response has been depleted,an
influx of inflammatory cytokines results in increased pathological
responses (12, 50).
PBMCs proliferation was not related to infection intensity.
Both PHA and PMA directly stimulate or activate cells, bypass-
ing the requirement for surface receptor stimulation (51, 52). The
differing relationships between PHA/PMA stimulated PBMC pro-
liferation and CD3ζ with infection intensity suggests that infection
related downregulation of CD3ζ does not intrinsically impair cell
function, and supports evidence of a reversible suppression of cell
function related to the presence of schistosome worms (22).
Protective schistosome acquired immunity has been shown in
several studies to be associated with high levels of IgE against adult
worm antigens, and moreover a high IgE:IgG4 is associated with
protection against reinfection (45, 46). In agreement with this, here
we observed a negative association between IgE:IgG4 and infection
intensity, as well as a positive and significant relationship between
IgG4 and infection intensity, consistent with previous observations
(53, 54).
In relating levels of CD3ζ to markers for specific schistosome
immune responses, we show that IgA against SWAP was nega-
tively related to CD3ζ levels, as was IgE:IgG4 against SWAP. The
IgE:IgG4 is associated with developing immunity (45), indicating a
potential relationship between developing immunity in conjunc-
tion with lower CD3ζ. IgG4 has been reported to be related to
pathology (9, 55), thus the relationship of higher levels of CD3ζ
with higher IgG4 levels in relation to IgE (low IgE:IgG4) sup-
ports the hypothesis that CD3ζ is downregulated as a protective
mechanism against parasite related immune damage and may
thus be associated with pathological immune responses. In con-
trast to IgE:IgG4, previous studies from Zimbabwe have shown
IgA to be associated with susceptibility to infection, observing
decreases in IgA levels with chemotherapeutic treatment (43),
as well as lower levels in uninfected adults (42). Schistosomi-
asis is a disease, which displays dynamic changes in immune
correlates throughout the course of infection (42, 56), with indi-
viduals living in endemic areas eventually developing protective
immunity to infection (57, 58) and an immune profile that is
skewed toward a Th2 dominant profile, while individuals who
remain infected display a mixed Th1/Th2 environment (44).
It is plausible that the downregulated T cell activity in schis-
tosome infected individuals, observed here through decreased
CD3ζ expression, may be contributing to the altered profiles
seen in infection, not only preventing a pathological immune
response, but also helping create an environment conducive
to developing immunity toward infection. Further investigation
into the relationship between CD3ζ and immune correlates are
required to clarify the function of this marker during developing
immunity.
Given that chronic schistosome infection can limit T cell
responses to vaccine antigens (24, 27), and in previous studies
in this cohort both auto-immune inflammation (59) and allergic
reactivity (60) were reduced in people with higher schistosome
infection, it is possible that the downregulation of the CD3ζ
chain we observe may contribute to these phenomena. Indeed,
the precise mechanisms leading to this downregulation of the
CD3ζ chain in schistosome infection have important implica-
tions for fields such as vaccine development, where a fully func-
tioning immune system is required to achieve optimal vaccine
efficacy (61).
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While we did not investigate the mechanisms leading to the
downregulation of CD3ζ expression in schistosome infection,
there may be an association with myeloid cells and myeloid derived
suppressor cells (MDSC). For example, downregulation of the
CD3ζ chain has previously been found to be related to an increase
in activated MDSC in both human and murine studies (62, 63).
Specifically in chronic schistosome infection, previous studies
in this population, as well as elsewhere, have identified myeloid
derived dendritic cells (mDCs) as having an altered expression
level (37, 64). Furthermore, in experimental models of helminth
infection, alternatively activated macrophages have been impli-
cated as having a regulatory role (65). In humans, neutrophils have
also been reported to act as modulators of T cell CD3ζ expression
via l-arginine metabolism in inflammation and various patho-
logical conditions (66, 67), and may be an area for further inves-
tigation in schistosome infection. Further identification of the
mechanisms leading to immune suppression observed in helminth
infection (22, 23), and the relationship between downregulation
of CD3ζ observed here and clinical indices of helminth-mediated
pathology is therefore warranted.
Overall, this study has shown a downregulation of CD3ζ lev-
els in conjunction with increasing schistosome infection. Previous
reports of CD3ζ expression being related to T cell activity, and
the observation that levels of this marker are related to PBMC
proliferation identifies downregulation of CD3ζ as a novel mecha-
nism for immunoregulation during helminth infection in humans.
Furthermore, we provide evidence of association between CD3ζ
and markers for protective immunity. Mechanistic studies, per-
haps including in vitro cell culture and blocking antibodies, will
elucidate if the association is causal and also if elevated levels of
CD3ζ expression mediate, or are a marker of, protective immunity.
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